BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11967509)

  • 1. Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes.
    Jenkins SM; Head BB; Hauth JC
    Am J Obstet Gynecol; 2002 Apr; 186(4):790-5. PubMed ID: 11967509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: onset at < or =28.0 weeks' gestation.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Dec; 183(6):1475-9. PubMed ID: 11120513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
    Bombrys AE; Barton JR; Nowacki EA; Habli M; Pinder L; How H; Sibai BM
    Am J Obstet Gynecol; 2008 Sep; 199(3):247.e1-6. PubMed ID: 18771971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit.
    Drakeley AJ; Le Roux PA; Anthony J; Penny J
    Am J Obstet Gynecol; 2002 Feb; 186(2):253-6. PubMed ID: 11854645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expectant management of severe preeclampsia presenting before 25 weeks of gestation.
    Sezik M; Ozkaya O; Sezik HT; Yapar EG
    Med Sci Monit; 2007 Nov; 13(11):CR523-527. PubMed ID: 17968301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria.
    Newman MG; Robichaux AG; Stedman CM; Jaekle RK; Fontenot MT; Dotson T; Lewis DF
    Am J Obstet Gynecol; 2003 Jan; 188(1):264-8. PubMed ID: 12548227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
    Haddad B; Barton JR; Livingston JC; Chahine R; Sibai BM
    Am J Obstet Gynecol; 2000 Aug; 183(2):444-8. PubMed ID: 10942484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?
    Abramovici D; Friedman SA; Mercer BM; Audibert F; Kao L; Sibai BM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):221-5. PubMed ID: 9914607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
    Sibai BM; Hauth J; Caritis S; Lindheimer MD; MacPherson C; Klebanoff M; VanDorsten JP; Landon M; Miodovnik M; Paul R; Meis P; Thurnau G; Dombrowski M; Roberts J; McNellis D
    Am J Obstet Gynecol; 2000 Apr; 182(4):938-42. PubMed ID: 10764477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subsequent pregnancy outcome in women with a history of preeclampsia and/or HELLP syndrome].
    Cathelain-Soland S; Coulon C; Subtil D; Houfflin-Debarge V; Deruelle P
    Gynecol Obstet Fertil; 2010 Mar; 38(3):166-72. PubMed ID: 20185355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Adverse Maternal Outcomes between Early- and Late-Onset Superimposed Preeclampsia.
    Onishi K; Seagraves E; Baraki D; Donaldson T; Barake C; Abuhamad A; Huang JC; Kawakita T
    Am J Perinatol; 2024 May; 41(S 01):e2010-e2016. PubMed ID: 37207676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for severe preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome, and eclampsia at preterm and term gestation: a population-based study.
    Lisonkova S; Bone JN; Muraca GM; Razaz N; Wang LQ; Sabr Y; Boutin A; Mayer C; Joseph KS
    Am J Obstet Gynecol; 2021 Nov; 225(5):538.e1-538.e19. PubMed ID: 33974902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Criteria of pregnancy termination in women with preeclampsia].
    Haddad B; Louis-Sylvestre C; Doridot V; Touboul C; Abirached F; Paniel BJ
    Gynecol Obstet Fertil; 2002 Jun; 30(6):467-73. PubMed ID: 12146147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity and mortality of patients with preeclampsia or HELLP syndrome transferred in intensive care].
    Sabbah-Briffaut E; Bourzoufi K; Fourrier F; Subtil D; Houfflin-Debarge V; Deruelle P
    Presse Med; 2009 Jun; 38(6):872-80. PubMed ID: 19186027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, risk factors and feto-maternal outcomes of abruptio placentae in Northern Tanzania: a registry-based retrospective cohort study.
    Macheku GS; Philemon RN; Oneko O; Mlay PS; Masenga G; Obure J; Mahande MJ
    BMC Pregnancy Childbirth; 2015 Oct; 15():242. PubMed ID: 26446879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and neonatal complications in women with medical comorbidities and preeclampsia.
    Tanner MS; Malhotra A; Davey MA; Wallace EM; Mol BW; Palmer KR
    Pregnancy Hypertens; 2022 Mar; 27():62-68. PubMed ID: 34942478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation.
    Chames MC; Haddad B; Barton JR; Livingston JC; Sibai BM
    Am J Obstet Gynecol; 2003 Jun; 188(6):1504-7; discussion 1507-8. PubMed ID: 12824985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.